Sumitomo, Shuji
Nagafuchi, Yasuo
Tsuchida, Yumi
Tsuchiya, Haruka
Ota, Mineto
Ishigaki, Kazuyoshi
Suzuki, Akari
Kochi, Yuta
Fujio, Keishi
Yamamoto, Kazuhiko
Article History
Received: 15 April 2018
Accepted: 4 July 2018
First Online: 5 November 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: S.S. received honoraria from AbbVie, Eisai, Chugai, Takeda, Bristol-Myers Squibb, Astrazeneca and UCB. K.F. received speaking fees and/or honoraria from Astellas, Bristol-Myers Squibb, Daiichi-Sankyo, MitsubishiTanabe, Pfizer, Santen, Takeda, Chugai, Eisai, Taisho Toyama, UCB, and Janssen. K.Y. received speaking fees and/or honoraria from AbbVie, Astellas, Bristol-Myers Squibb, Daiichi-Sankyo, MitsubishiTanabe, Pfizer, Sanofi, Santen, Takeda, Teijin, Boehringer Ingelheim, Chugai, Eisai, Ono, Taisho Toyama, UCB, ImmunoFuture, Asahi Kasei, and Janssen. All other authors declare no competing financial interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.